Trademark: 79087255
Status Date
Friday, July 27, 2012
Registration Number
3922322
Registration Date
Tuesday, February 22, 2011
Filing Date
Saturday, June 19, 2010
Published for Opposition
Tuesday, December 7, 2010
Cancellation Date
Monday, April 23, 2012
5 Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
May 11, 2012
Death Of International Registration
Jul 24, 2011
Notification Processed By Ib
Apr 14, 2011
Final Disposition Notice Sent To Ib
Apr 14, 2011
Final Disposition Processed
Mar 24, 2011
Grant Of Protection Created, To Be Sent To Ib
Feb 22, 2011
Registered-Principal Register
Dec 7, 2010
Published For Opposition
Dec 2, 2010
Attorney Revoked And/Or Appointed
Dec 2, 2010
Teas Revoke/Appoint Attorney Received
Nov 17, 2010
Notice Of Publication
Nov 2, 2010
Law Office Publication Review Completed
Nov 2, 2010
Assigned To Lie
Oct 19, 2010
Approved For Pub - Principal Register
Oct 19, 2010
Application Filing Receipt Mailed
Oct 15, 2010
Assigned To Examiner
Oct 15, 2010
New Application Office Supplied Data Entered In Tram
Oct 14, 2010
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
